Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Prescription Drug Marketing Act of 1987, 47815-47816 [E6-13609]
Download as PDF
<![CDATA[
47815
Federal Register / Vol. 71, No. 160 / Friday, August 18, 2006 / Notices
and activities, and also assists
independent panel reviewers, ANA staff
and the ANA Commissioner during the
review and funding decision process.
The information in OPR is being
collected on a quarterly basis to monitor
the performance of grantees and better
gauge grantee progress. The
Number of
respondents
Instrument
OWP ..............................................................................................................
OPR ...............................................................................................................
Project Abstract .............................................................................................
Estimated Total Annual Burden
Hours: 2,850.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, 725 17th Street, NW.,
Washington, DC 20503, attn: Desk
Officer for ACF, e-mail address:
Katherine_T._Astrich@omb.eop.gov.
Dated: August 14, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–7015 Filed 8–17–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
jlentini on PROD1PC65 with NOTICES
Office Of Community Services;
Community Economic Development
Program
Office of Community Services,
Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Replacement Grant.
AGENCY:
VerDate Aug<31>2005
18:35 Aug 17, 2006
Jkt 208001
utilized by applicants, independent
reviewers, ANA staff and the ANA
Commissioner.
Respondents: Tribal Govt., Native
non-profits, Tribal Colleges &
Universities.
standardized format will allow ANA to
report results across all its program
areas and flag grantees that may need
additional training and/or technical
assistance to successfully implement
their projects.
The Project Abstract provides crucial
information in a concise format that is
Annual Burden Estimates
Number of
responses per
respondent
500
275
500
CFDA#: 93.570.
Legislative Authority: The Community
Services Block Grant (CSBG) Act of
1981, as amended by section 680 (a)(2)
of the Community Opportunities,
Accountability, and Training and
Educational Services Act of 1998.
Amount of Award: $663,263.00.
Project Period: September 30, 2005 to
September 29, 2008.
SUMMARY: The purpose of the
Community Economic Development
(CED) grants is to create new
employment and business development
opportunities for low-income
individuals. The Office of Community
Services (OCS) awarded a $663,263 CED
grant (Grant No. 90EE0720) to Hall
Neighborhood House in Bridgeport,
Connecticut, on September 29, 2005.
Prior to the expenditure of any of the
grant funds, the grantee informed OCS
in a letter dated April 17, 2006, that it
wished to ‘‘relinquish the management
and operation of this program effective
immediately.’’ The letter stated the
grantee’s ‘‘current financial instability’’
as the reason for the action.
In an attempt not to lose the benefits
for the community that were intended
through the CED grant, OCS identified
a possible replacement recipient: Action
for Bridgeport Community
Development, Inc (ABCD). The
organization is being considered as a
replacement recipient for the following
reasons:
• ABCD is a previously successful
CED grantee (grant #90EE0546).
• ABCD is headquartered
approximately a mile and a half from
the offices of Hall Neighborhood House
(HNH) in Bridgeport, CT and will serve
the same community. Also, ABCD and
HNH have worked together in the past
and reportedly have maintained a good
working relationship.
• ABCD has a significantly
sophisticated budget to manage this
project effectively. (In 2003, the
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
4
1
Total burden
hours
3
1
.5
1,500
1,100
250
organization had gross receipts of
approximately $20 million.).
• ABCD was recently selected by the
Head Start Bureau to be the successor
grantee of HNH’s active Head Start
grant.
• ACF Region I Administrator Hugh
Galligan speaks highly of the
performance of ABCD and has
recommended that it be the replacement
recipient.
OCS has received and reviewed an
application from ABCD. Upon finding
that the proposed project is significantly
similar to the one chosen for funding
through HNH, OCS has requested that
ABCD be approved as the permanent
replacement recipient for Grant No.
90EE0720.
FOR FURTHER INFORMATION CONTACT:
Office of Community Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Thom Campbell—(202) 401–
5483, tcampbell@acf.hhs.gov.
Dated: August 4, 2006.
Josephine B. Robinson,
Director, Office of Community Services.
[FR Doc. E6–13667 Filed 8–17–06; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0081]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Prescription Drug Marketing Act of
1987
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Prescription Drug Marketing Act of
E:\FR\FM\18AUN1.SGM
18AUN1
47816
Federal Register / Vol. 71, No. 160 / Friday, August 18, 2006 / Notices
1987’’ has been approved by the Office
of Management and Budget (OMB)
under the Paperwork Reduction Act of
1995.
FOR FURTHER INFORMATION CONTACT: Liz
Berbakos, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–1482.
SUPPLEMENTARY INFORMATION: In the
Federal Register of June 2, 2006 (71 FR
32097), the agency announced that the
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0435. The
approval expires on August 31, 2009. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
Place: National Institutes of Health, 6130
Executive Blvd., EPN/6053, Rockville, MD
20852, (Telephone Conference Call).
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Administrator,
Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8057, Bethesda, MD 20892–
8329, (301) 496–7421,
kerwinm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 10, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–13609 Filed 8–17–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–7016 Filed 8–17–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
BILLING CODE 4160–01–S
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4), and 552b(c)(6), as amended.
The contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel—SBIR topic
207 (Phase II), ‘‘Multi-Purpose
Radiophamaceutical Synthesis Platforms’’.
Date: September 5, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
VerDate Aug<31>2005
18:35 Aug 17, 2006
Jkt 208001
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Education and Cancer Development.
Date: September 25, 2006.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Jeannette F Korczak, PhD,
Scientific Review Administrator, Review
Training Resources Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301–496–9767,
korczak@mail.nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
I—Career Development.
Date: September 26–27, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Robert Bird, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, National
Cancer Institute, National Institutes of
Health, 6116 Executive Blvd., Room 8113,
MSC 8328, Bethesda, MD 20892–8328, 301–
496–7978, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Prevention,
Control and Population Sciences.
Date: September 27–29, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Hasnaa Shafik, MD, PhD,
Scientific Review Administrator, Division of
Extramural Activities, RPRB, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8037, Bethesda, MD
20892, (301) 451–4757,
shafikh@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Innovations in Cancer Sample Preparation,
STTR, SBIR.
Date: October 4, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel and
Conf. Center, 5701 Marinelli Road, Bethesda
North, MD 20852.
Contact Person: Gerald G. Lovinger, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8101,
Bethesda, MD 20892–8329, 301/496–7987.
lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Clinical
Program Project Special Emphasis Panel.
Date: October 4–6, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton, 8727 Colesville Road, Silver
Spring, MD 20910.
Contact Person: Carol Lyman, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd, Room 8119, Bethesda, MD
20892–8328, 301–451–4761,
lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Discovery
and Development.
Date: October 4–6, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 71, Number 160 (Friday, August 18, 2006)]
[Notices]
[Pages 47815-47816]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13609]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0081]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Prescription Drug Marketing Act of
1987
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Prescription Drug Marketing Act of
[[Page 47816]]
1987'' has been approved by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Liz Berbakos, Office of Management
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-1482.
SUPPLEMENTARY INFORMATION: In the Federal Register of June 2, 2006 (71
FR 32097), the agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0435.
The approval expires on August 31, 2009. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.fda.gov/ohrms/dockets.
Dated: August 10, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-13609 Filed 8-17-06; 8:45 am]
BILLING CODE 4160-01-S
